Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
212
datasets available to search
ShareScore release 0.9.0
Dataset results
212 results for “Zika”
Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults
ClinicalTrials.gov study NCT04064905. IPD Sharing: NO. Countries: 2. Publications: 1.
VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents
ClinicalTrials.gov study NCT03110770. IPD Sharing: NO. Countries: 9. Publications: 4.
Data from: Preventing Zika virus infection during pregnancy using a seasonal window of opportunity for conception
Open the record for dataset details and reuse information.
Data from: Spatiotemporal incidence of Zika and associated environmental drivers for the 2015-2016 epidemic in Colombia
Open the record for dataset details and reuse information.
FIGURE 2 in The Asian tiger mosquito, Aedes (Stegomyia) albopictus (Skuse), a vector of dengue, chikungunya and zika viruses, reaches Portugal (Diptera: Culicidae)
FIGURE 2. Portuguese Aedes albopictus females seeking human blood. Note characteristic scutal white stripe, distinct silvery-white scales on the maxillary palpi and tarsi, as well as narrow scales over the wing root and silvery-white basolateral abdominal tergal markings.
FIGURE 1 in The Asian tiger mosquito, Aedes (Stegomyia) albopictus (Skuse), a vector of dengue, chikungunya and zika viruses, reaches Portugal (Diptera: Culicidae)
FIGURE 1. Distribution of Aedes albopictus in the Iberian Península. In green, distribution in Spain according to Collantes et al. (2016). In red, highlighted by arrow, new occurrence in Portugal.
FIGURE 3 in The Asian tiger mosquito, Aedes (Stegomyia) albopictus (Skuse), a vector of dengue, chikungunya and zika viruses, reaches Portugal (Diptera: Culicidae)
FIGURE 3. Biting activity of Ae. albopictus assessed by human-bait catches. Specimens arriving to bite were captured every 15 minutes to avoid recapture. The x axis is a timeline of 15-minute intervals; the y axis is an average of the three days of sampling.
Skills attained by infants with Congenital Zika Syndrome: Pilot data from Brazil
<p>The recent Zika outbreak and its link to microcephaly and other birth defects in infants exposed in utero have garnered widespread international attention. Based on the severity of birth defects the extent of impairment in these infants is expected to be profound; however, virtually nothing is known regarding the developmental and behavioral sequela of congenital Zika syndrome. This pilot study collected parent-reported patterns of development and sleep in 47 infants with confirmed congenital Zika syndrome who are being followed for clinical services at the Altino Ventura Foundation (FAV) in Recife, Brazil. With assistance from clinicians at FAV, caregivers completed Brazilian Portuguese versions of the Ages and Stages Questionnaire, 3<sup>rd</sup> edition (ASQ-3) and the Brief Infant Sleep Questionnaire (BISQ). All infants were between 13–22 months of age at the time of the assessment. At 16 months of age, none of the children displayed age appropriate developmental skills. Most (~ 75%) mastered some communication and gross motor skills at around a 6–8-month level. Communication and gross motor skills were relative strengths for the sample, while problem-solving and fine motor skills were relative weaknesses. Sleep was noted to be a problem for around 18% of the sample. In utero exposure to the Zika virus will have lifelong consequences for affected children and their families. Understanding the developmental and behavioral trajectories of affected infants will help identify appropriate family supports to improve quality of life.</p>
Unravelling the metabolic alterations induced by Zika infection in prostate epithelial (PNT1a) and adenocarcinoma (PC-3) cell lines
<p>Unravelling the metabolic alterations induced by Zika infection in prostate epithelial (PNT1a) and adenocarcinoma (PC-3) cell lines</p>
Evaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP Challenge
ClinicalTrials.gov study NCT06805487. IPD Sharing: NO. Countries: 1. Publications: 3.
Pilot Study to Detect Zika Virus in Sperm
ClinicalTrials.gov study NCT02874456. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed
ClinicalTrials.gov study NCT02963909. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ZIKA Vaccine in Naive Subjects
ClinicalTrials.gov study NCT02952833. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Prospective Cohort Study of HIV and Zika in Infants and Pregnancy
ClinicalTrials.gov study NCT03263195. IPD Sharing: YES. Countries: 3. Publications: 0.
Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults
ClinicalTrials.gov study NCT02840487. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Zika in Infants and Pregnancy (ZIP)
ClinicalTrials.gov study NCT02856984. IPD Sharing: YES. Countries: 6. Publications: 20.
Vertical Exposure to Zika Virus and Its Consequences for Child Neurodevelopment (ZIKVIRUSIFF)
ClinicalTrials.gov study NCT03255369. IPD Sharing: YES. Countries: 1. Publications: 5.
INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections
ClinicalTrials.gov study NCT03037164. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Evaluation of Medical Conditions Associated With Zika Virus Infection in Managua, Nicaragua
ClinicalTrials.gov study NCT04182685. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Zika Virus Infection's Neonatal and Pediatric Consequences in French Department of America
ClinicalTrials.gov study NCT02810210. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.